Autoimmune Cytopenias as a Sign of Primary Immunodeficiency.
Status unconfirmed · Not applicable
Conditions studied: Cytopenia
In brief
Autoimmune cytopenias resistant to treatment are among the most common clinical manifestations observed in patients with congenital alterations of the immune system, such as primary immunodeficiencies (PI). The exact contribution of immune system alterations to the pathogenesis of autoimmune cytopenias has not yet been fully elucidated. Moreover, conventionally employed therapeutic strategies often fail, leading to increased healthcare costs, high morbidity, and even mortality. Therefore, there is a need to establish clinical guidelines for diagnosis and to identify early biomarkers capable of identifying individuals responsive to therapy. Thus, a systematic approach to the study of such pathologies will allow for the identification of early biomarkers and facilitate the development of targeted therapeutic strategies
Key facts
- Study ID
- NCT06276036
- Run by
- Meyer Children's Hospital IRCCS
- People needed
- 53
- Starts
- 2019-07-23
- Expected to finish
- 2025-06-01
- Last updated by the study team
- 2024-03-29
Who can join
Age: 1 and older, up to 17. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Clinical and hematological diagnosis of autoimmune cytopenia
- Additional inclusion criteria for classification into responder vs. non-responder:
- For immune thrombocytopenic purpura: platelet count increase >30,000 with at least a twofold increase from pre-treatment value
- For autoimmune hemolytic anemia: Hb ≥10 g/dL with an increase of at least 2 g/dL compared to baseline
You may not qualify if…
- Transient cytopenia without confirmation of autoimmunity where frontline treatment is not necessary
Where it is running
- University of South Florida — Tampa, Florida, United States
- Ghent University Hospital — Ghent, Belgium
- Clinica Pediatrica - Università di Catania — Catania, Italy
- Meyer Children's Hospital IRCCS — Florence, Italy
- IRCCS Istituto Giannina Gaslini — Genova, Italy
- Azienda Ospedaliero Universitaria Pisana — Pisa, Italy
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.